Cargando…

Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System

Treatment of central nervous system (CNS) disorders is challenging using conventional delivery strategies and routes of administration because of the presence of the blood–brain barrier (BBB). This BBB restricts the permeation of most of the therapeutics targeting the brain because of its impervious...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Manisha, Jain, Neha, Kanoujia, Jovita, Hussain, Zahid, Gorain, Bapi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988043/ https://www.ncbi.nlm.nih.gov/pubmed/35401164 http://dx.doi.org/10.3389/fphar.2022.865590

Ejemplares similares

Editorial: Intranasal Delivery of Central Nervous System Active Drugs: Opportunities and Challenges
por: Rodrigues, Márcio, et al.
Publicado: (2022)

Establishment of an Olfactory Region-specific Intranasal Delivery Technique in Mice to Target the Central Nervous System
por: Flamm, Johannes, et al.
Publicado: (2022)

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
por: Fortuna, Ana, et al.
Publicado: (2022)

Current State and Future Directions of Intranasal Delivery Route for Central Nervous System Disorders: A Scientometric and Visualization Analysis
por: Wu, Haiyang, et al.
Publicado: (2021)

Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders
por: Shah, Pranav, et al.
Publicado: (2022)

Development of In-Situ Spray for Local Delivery of Antibacterial Drug for Hidradenitis Suppurativa: Investigation of Alternative Formulation
por: Wong, Yoke Lan, et al.
Publicado: (2021)

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
por: Crowe, Tyler P., et al.
Publicado: (2022)

Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma
por: Manni, Luigi, et al.
Publicado: (2021)

Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system
por: McGowan, Jeremy WD, et al.
Publicado: (2016)

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
por: Hanson, Leah R, et al.
Publicado: (2008)

Recent Advances in Pharmaceutical Cocrystals: From Bench to Market
por: Kumar Bandaru, Ravi, et al.
Publicado: (2021)

Exploiting Focused Ultrasound to Aid Intranasal Drug Delivery for Brain Therapy
por: Barbato, Gaetano, et al.
Publicado: (2022)

Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies
por: Bhanderi, Mansi, et al.
Publicado: (2021)

Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance
por: Martins, Paulo J.F., et al.
Publicado: (2010)

Tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative in vitro evaluations
por: Yeo, Eileen, et al.
Publicado: (2021)

Site-Specific Vesicular Drug Delivery System for Skin Cancer: A Novel Approach for Targeting
por: Pandey, Manisha, et al.
Publicado: (2021)

Intranasal Treatment of Central Nervous System Dysfunction in Humans
por: Chapman, Colin D., et al.
Publicado: (2012)

Promising Drug Delivery Approaches to Treat Microbial Infections in the Vagina: A Recent Update
por: Pandey, Manisha, et al.
Publicado: (2020)

Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases
por: Su, Yu, et al.
Publicado: (2020)

Budesonide-Loaded Pectin/Polyacrylamide Hydrogel for Sustained Delivery: Fabrication, Characterization and In Vitro Release Kinetics
por: Pandey, Manisha, et al.
Publicado: (2021)

Recent Advances in the Use of Focused Ultrasound for Magnetic Resonance Image-Guided Therapeutic Nanoparticle Delivery to the Central Nervous System
por: Fisher, Delaney G., et al.
Publicado: (2019)

Medicinal Cannabis and Central Nervous System Disorders
por: Ortiz, Yuma T., et al.
Publicado: (2022)

Optimizing Absorption for Intranasal Delivery of Drugs Targeting the Central Nervous System Using Alkylsaccharide Permeation Enhancers
por: Madden, Stuart, et al.
Publicado: (2023)

Nanoconstructs for theranostic application in cancer: Challenges and strategies to enhance the delivery
por: Mishra, Shivani, et al.
Publicado: (2023)

Central nervous system uptake of intranasal glutathione in Parkinson’s disease
por: Mischley, Laurie K, et al.
Publicado: (2016)

A Review on Central Nervous System Effects of Gastrodin
por: Liu, Yuan, et al.
Publicado: (2018)

Mucoadhesive Nanocarriers as a Promising Strategy to Enhance Intracellular Delivery against Oral Cavity Carcinoma
por: Pandey, Manisha, et al.
Publicado: (2022)

Advancement on Sustained Antiviral Ocular Drug Delivery for Herpes Simplex Virus Keratitis: Recent Update on Potential Investigation
por: Pandey, Manisha, et al.
Publicado: (2020)

Nanocarriers-Assisted Needle-Free Vaccine Delivery Through Oral and Intranasal Transmucosal Routes: A Novel Therapeutic Conduit
por: Mangla, Bharti, et al.
Publicado: (2022)

Potential of Stimuli-Responsive In Situ Gel System for Sustained Ocular Drug Delivery: Recent Progress and Contemporary Research
por: Pandey, Manisha, et al.
Publicado: (2021)

Pulsatile Bi-Directional Aerosol Flow Affects Aerosol Delivery to the Intranasal Olfactory Region: A Patient-Specific Computational Study
por: Farnoud, Ali, et al.
Publicado: (2021)

A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis
por: Cheng, Shen Nam, et al.
Publicado: (2020)

Antipsychotic treatments; focus on lurasidone
por: Sumiyoshi, Tomiki
Publicado: (2013)

Targeting Mediators of Smoking Persistence with Intranasal Insulin
por: Hamidovic, Ajna
Publicado: (2017)

Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children
por: Wang, Cheng-Yu, et al.
Publicado: (2019)

Axon growth inhibition by RhoA/ROCK in the central nervous system
por: Fujita, Yuki, et al.
Publicado: (2014)

Molecular imaging as a guide for the treatment of central nervous system disorders
por: Kim, Euitae, et al.
Publicado: (2013)

The Case for TAAR1 as a Modulator of Central Nervous System Function
por: Rutigliano, Grazia, et al.
Publicado: (2018)

Role of TREK-1 in Health and Disease, Focus on the Central Nervous System
por: Djillani, Alaeddine, et al.
Publicado: (2019)

Mechanisms of Modulation of Ferroptosis and Its Role in Central Nervous System Diseases
por: Tan, Qingyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f9qssu0nshm0evuad8qudkgc45